Pegfilgrastim: a recent advance in the prophylaxis of chemotherapy-induced neutropenia.

Item

http://www.wikidata.org/entity/Q35860879

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Pegfilgrastim: a recent advance in the prophylaxis of chemotherapy-induced neutropenia.

@ast

Pegfilgrastim: a recent advance in the prophylaxis of chemotherapy-induced neutropenia.

@en

type

Item

label

Pegfilgrastim: a recent advance in the prophylaxis of chemotherapy-induced neutropenia.

@ast

Pegfilgrastim: a recent advance in the prophylaxis of chemotherapy-induced neutropenia.

@en

prefLabel

Pegfilgrastim: a recent advance in the prophylaxis of chemotherapy-induced neutropenia.

@ast

Pegfilgrastim: a recent advance in the prophylaxis of chemotherapy-induced neutropenia.

@en

P1476

Pegfilgrastim: a recent advance in the prophylaxis of chemotherapy-induced neutropenia.

@en

P2093

Waladkhani AR

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy dose reduction and delay in clinical practice. evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer.

Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs.

Impact of neutropenia on delivering planned adjuvant chemotherapy: UK audit of primary breast cancer patients.

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy.

Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer.

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer.

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy.

Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma.

Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma.

Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

P304

371-379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2354.2004.00503.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15305906

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy